|

TriPRIL CAR T Cells Clinical Trials

1 actively recruiting trial across 1 location

Pipeline

Phase 1: 1

Top Sponsors

  • Marcela V. Maus, M.D.,Ph.D.1

Indications

  • Multiple Myeloma in Relapse1
  • Refractory Multiple Myeloma1
  • Multiple Myeloma1
  • Cancer1

Boston, Massachusetts1 trial

TriPRIL CAR T Cells in Multiple Myeloma

Massachusetts General Hospital Cancer Center

Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.